HMGB1 and ischemic stroke: Recombinant human thrombomodulin (rhsTM) improves cerebral ischemic injury in mice without hemorrhagic complications through HMGB1 inhibition and has a longer time window to improve the prognosis of ischemic stroke potentially, and its mechanism of action needs to be further investigated [191].